LEVOCETIRIZINE DIHYDROCHLORIDE tablet film coated Estados Unidos - inglés - NLM (National Library of Medicine)

levocetirizine dihydrochloride tablet film coated

sun pharma global fze - levocetirizine dihydrochloride (unii: sod6a38aga) (levocetirizine - unii:6u5ea9rt2o) - levocetirizine dihydrochloride 5 mg

Levocetirizine Glenmark 5 mg Film-coated Tablets Irlanda - inglés - HPRA (Health Products Regulatory Authority)

levocetirizine glenmark 5 mg film-coated tablets

glenmark pharmaceuticals europe limited - levocetirizine dihydrochloride - film-coated tablet - 5 milligram(s) - piperazine derivatives; levocetirizine

LEVOCETIRIZINE DIHYDROCHLORIDE tablet, film coated Estados Unidos - inglés - NLM (National Library of Medicine)

levocetirizine dihydrochloride tablet, film coated

proficient rx lp - levocetirizine dihydrochloride (unii: sod6a38aga) (levocetirizine - unii:6u5ea9rt2o) - levocetirizine dihydrochloride tablets are indicated for the relief of symptoms associated with perennial allergic rhinitis in children 6 years of age and older. levocetirizine dihydrochloride tablets are indicated for the treatment of the uncomplicated skin manifestations of chronic idiopathic urticaria in adults and children 6 years of age and older. the use of levocetirizine dihydrochloride tablets are contraindicated in: patients with known hypersensitivity to levocetirizine or any of the ingredients of levocetirizine dihydrochloride tablets, or to cetirizine. observed reactions range from urticaria to anaphylaxis [see adverse reactions ( 6.2) ]. patients with end-stage renal disease (cl cr < 10 ml/min) and patients undergoing hemodialysis children 6 months to 11 years of age with impaired renal function pregnancy category b there are no adequate and well-controlled studies in pregnant women. because animal reproduction studies ar

LEVOCETIRIZINE DIHYDROCHLORIDE tablet, film coated Estados Unidos - inglés - NLM (National Library of Medicine)

levocetirizine dihydrochloride tablet, film coated

nucare pharmaceuticals,inc. - levocetirizine dihydrochloride (unii: sod6a38aga) (levocetirizine - unii:6u5ea9rt2o) - levocetirizine dihydrochloride tablets are indicated for the relief of symptoms associated with perennial allergic rhinitis in children 6 years of age and older. levocetirizine dihydrochloride tablets are indicated for the treatment of the uncomplicated skin manifestations of chronic idiopathic urticaria in adults and children 6 years of age and older. the use of levocetirizine dihydrochloride tablets are contraindicated in: patients with known hypersensitivity to levocetirizine or any of the ingredients of levocetirizine dihydrochloride tablets, or to cetirizine. observed reactions range from urticaria to anaphylaxis [see adverse reactions ( 6.2) ]. patients with end-stage renal disease (cl cr < 10 ml/min) and patients undergoing hemodialysis children 6 months to 11 years of age with impaired renal function risk summary available data from published litera

Levocetirizine dihydrochloride 5 mg Film-Coated Tablets Irlanda - inglés - HPRA (Health Products Regulatory Authority)

levocetirizine dihydrochloride 5 mg film-coated tablets

bristol laboratories limited - levocetirizine dihydrochloride - film-coated tablet - 5 milligram(s) - piperazine derivatives; levocetirizine

Levocetirizine Krka 5mg film-coated tablets Irlanda - inglés - HPRA (Health Products Regulatory Authority)

levocetirizine krka 5mg film-coated tablets

krka, d.d., novo mesto - levocetirizine dihydrochloride - film-coated tablet - 5 milligram(s) - piperazine derivatives; levocetirizine

Levocetirizine dihydrochloride 5 mg Film-Coated Tablets Irlanda - inglés - HPRA (Health Products Regulatory Authority)

levocetirizine dihydrochloride 5 mg film-coated tablets

brillpharma (ireland) limited - levocetirizine dihydrochloride - film-coated tablet - 5 milligram(s) - piperazine derivatives; levocetirizine

LEVOCETIRIZINE DIHYDROCHLORIDE tablet Estados Unidos - inglés - NLM (National Library of Medicine)

levocetirizine dihydrochloride tablet

proficient rx lp - levocetirizine dihydrochloride (unii: sod6a38aga) (levocetirizine - unii:6u5ea9rt2o) - levocetirizine dihydrochloride tablets are indicated for the treatment of the uncomplicated skin manifestations of chronic idiopathic urticaria in adults and children 6 years of age and older. the use of levocetirizine dihydrochloride is contraindicated in: patients with known hypersensitivity to levocetirizine or any of the ingredients of levocetirizine dihydrochloride tablets, or to cetirizine. observed reactions range from urticaria to anaphylaxis [see adverse reactions (6.2)]. patients with end-stage renal disease (clcr < 10 ml/min) and patients undergoing hemodialysis children 6 months to 11 years of age with impaired renal function risk summary available data from published literature and postmarketing experience with levocetirizine use in pregnant women are insufficient to identify any drug-associated risks of miscarriage, birth defects, or adverse maternal or fetal outcomes. in animal reproduction studies, there was no evidence of fetal harm with administration of levocetirizine by the oral route to

LEVOCETIRIZINE DIHYDROCHLORIDE tablet Estados Unidos - inglés - NLM (National Library of Medicine)

levocetirizine dihydrochloride tablet

proficient rx lp - levocetirizine dihydrochloride (unii: sod6a38aga) (levocetirizine - unii:6u5ea9rt2o) - levocetirizine dihydrochloride tablets are indicated for the treatment of the uncomplicated skin manifestations of chronic idiopathic urticaria in adults and children 6 years of age and older. the use of levocetirizine dihydrochloride is contraindicated in: patients with known hypersensitivity to levocetirizine or any of the ingredients of levocetirizine dihydrochloride tablets, or to cetirizine. observed reactions range from urticaria to anaphylaxis [see adverse reactions (6.2)]. patients with end-stage renal disease (clcr < 10 ml/min) and patients undergoing hemodialysis children 6 months to 11 years of age with impaired renal function risk summary available data from published literature and postmarketing experience with levocetirizine use in pregnant women are insufficient to identify any drug-associated risks of miscarriage, birth defects, or adverse maternal or fetal outcomes. in animal reproduction studies, there was no evidence of fetal harm with administration of levocetirizine by the oral route to

Levocetirizine Glenmark 5 mg Film-coated Tablets Irlanda - inglés - HPRA (Health Products Regulatory Authority)

levocetirizine glenmark 5 mg film-coated tablets

glenmark arzneimittel gmbh - levocetirizine dihydrochloride - film-coated tablet - 5 milligram(s) - piperazine derivatives; levocetirizine